Zonisamide

Product NDC
71335-0125
11-digit product format
713350125
Labeler code
71335
Product ID
71335-0125_5f7dacf0-1078-4607-86e8-21db04fecb60
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Zonisamide
Dosage form
CAPSULE
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
ANDA077651
Marketing category
ANDA
Marketing start
2006-01-30
Marketing end
0000-00-00
Substance
ZONISAMIDE
Active strength
100 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
71335-0125-171335012501100 CAPSULE in 1 BOTTLE (71335-0125-1) 100 capsule2014-03-100000-00-00NoNoCurrent
71335-0125-27133501250290 CAPSULE in 1 BOTTLE (71335-0125-2) 90 capsule2014-03-100000-00-00NoNoCurrent
71335-0125-37133501250330 CAPSULE in 1 BOTTLE (71335-0125-3) 30 capsule2014-03-100000-00-00NoNoCurrent
71335-0125-47133501250460 CAPSULE in 1 BOTTLE (71335-0125-4) 60 capsule2014-03-100000-00-00NoNoCurrent
71335-0125-571335012505120 CAPSULE in 1 BOTTLE (71335-0125-5) 120 capsule2014-03-100000-00-00NoNoCurrent